Literature DB >> 29936600

Effects of epidural anesthesia on postoperative nausea and vomiting in laparoscopic gynecological surgery: a randomized controlled trial.

Hiroyuki Seki1,2, Kyoko Furumoto3,4, Masato Sato5, Aya Kagoya3, Hiroka Hashimoto3, Yoshihiro Sekiguchi3, Itsuo Nakatsuka3.   

Abstract

PURPOSE: Patients undergoing laparoscopic gynecological surgery are susceptible to postoperative nausea and vomiting (PONV). We hypothesized that a combination of epidural and general anesthesia to minimize intraoperative opioid administration would reduce the incidence of PONV following laparoscopic gynecological surgery.
METHODS: Women undergoing elective laparoscopic gynecological surgery were randomly assigned to receive general anesthesia alone (group G, n = 45) or general anesthesia with epidural anesthesia (group GE, n = 45). Patients in group G received fentanyl and remifentanil for intraoperative analgesia, and those in group GE received single-shot ropivacaine at the time of induction of anesthesia. The primary outcome was the incidence of PONV within 24 h of surgery. Secondary outcomes included the use of rescue metoclopramide within 24 h of surgery and the time to first incidence of PONV and first use of rescue metoclopramide.
RESULTS: The incidence of PONV within 24 h of surgery was 60.0% in group G and 44.4% in group GE [relative risk (RR): 0.53, 95% confidence interval (CI): 0.23-1.23, p = 0.14]. There were no intergroup differences in the use of rescue metoclopramide (40.0% in group G, 24.4% in group GE, RR: 0.49, 95% CI 0.20-1.20, p = 0.11) and the time to first incidence of PONV and first use of rescue metoclopramide (p = 0.20 and 0.12, respectively).
CONCLUSION: Minimizing intraoperative opioid administration by combining epidural and general anesthesia did not reduce the 24-h incidence of PONV or rescue metoclopramide use after laparoscopic gynecological surgery.

Entities:  

Keywords:  Epidural anesthesia; Gynecological surgery; Laparoscopic surgery; Postoperative nausea and vomiting

Mesh:

Substances:

Year:  2018        PMID: 29936600     DOI: 10.1007/s00540-018-2525-5

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  30 in total

1.  Comparison of prophylactic anti-emetic effects of ondansetron and dexamethasone in women undergoing day-case gynaecological laparoscopic surgery.

Authors:  M S Yuksek; H A Alici; A F Erdem; M Cesur
Journal:  J Int Med Res       Date:  2003 Nov-Dec       Impact factor: 1.671

Review 2.  Impact of epidural analgesia on mortality and morbidity after surgery: systematic review and meta-analysis of randomized controlled trials.

Authors:  Daniel M Pöpping; Nadia Elia; Hugo K Van Aken; Emmanuel Marret; Stephan A Schug; Peter Kranke; Manuel Wenk; Martin R Tramèr
Journal:  Ann Surg       Date:  2014-06       Impact factor: 12.969

3.  A postanesthetic recovery score.

Authors:  J A Aldrete; D Kroulik
Journal:  Anesth Analg       Date:  1970 Nov-Dec       Impact factor: 5.108

4.  The Analgesic Efficacy of Ultrasound-Guided Transversus Abdominis Plane Block in Adult Patients: A Meta-Analysis.

Authors:  Moira Baeriswyl; Kyle R Kirkham; Christian Kern; Eric Albrecht
Journal:  Anesth Analg       Date:  2015-12       Impact factor: 5.108

5.  Opioid-free total intravenous anaesthesia reduces postoperative nausea and vomiting in bariatric surgery beyond triple prophylaxis.

Authors:  P Ziemann-Gimmel; A A Goldfarb; J Koppman; R T Marema
Journal:  Br J Anaesth       Date:  2014-02-18       Impact factor: 9.166

Review 6.  Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery.

Authors:  D Korolija; S Sauerland; S Wood-Dauphinée; C C Abbou; E Eypasch; M García Caballero; M A Lumsden; B Millat; J R T Monson; G Nilsson; R Pointner; W Schwenk; A Shamiyeh; A Szold; E Targarona; B Ure; E Neugebauer
Journal:  Surg Endosc       Date:  2004-04-27       Impact factor: 4.584

7.  Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures.

Authors:  Hans J Gerbershagen; Sanjay Aduckathil; Albert J M van Wijck; Linda M Peelen; Cor J Kalkman; Winfried Meissner
Journal:  Anesthesiology       Date:  2013-04       Impact factor: 7.892

8.  Serious complications associated with spinal and epidural anaesthesia in Finland from 2000 to 2009.

Authors:  M T Pitkänen; U Aromaa; D A Cozanitis; J G Förster
Journal:  Acta Anaesthesiol Scand       Date:  2013-01-11       Impact factor: 2.105

9.  Nausea and vomiting after gynaecological laparoscopy depends upon the phase of the menstrual cycle.

Authors:  P Honkavaara; A M Lehtinen; J Hovorka; K Korttila
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

Review 10.  Transversus abdominis-plane block versus local anesthetic wound infiltration in lower abdominal surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Nanze Yu; Xiao Long; Jorge R Lujan-Hernandez; Julien Succar; Xin Xin; Xiaojun Wang
Journal:  BMC Anesthesiol       Date:  2014-12-15       Impact factor: 2.217

View more
  3 in total

Review 1.  Postoperative Nausea and Vomiting in Female Patients Undergoing Breast and Gynecological Surgery: A Narrative Review of Risk Factors and Prophylaxis.

Authors:  Marco Echeverria-Villalobos; Juan Fiorda-Diaz; Alberto Uribe; Sergio D Bergese
Journal:  Front Med (Lausanne)       Date:  2022-07-01

2.  Opioid-Sparing Analgesia Impacts the Perioperative Anesthetic Management in Major Abdominal Surgery.

Authors:  Miruna Jipa; Sebastian Isac; Artsiom Klimko; Mihail Simion-Cotorogea; Cristina Martac; Cristian Cobilinschi; Gabriela Droc
Journal:  Medicina (Kaunas)       Date:  2022-03-28       Impact factor: 2.948

3.  Inhalation of low-dose desflurane prevents the hemodynamic instability caused by target-controlled infusion of remifentanil and propofol during laparoscopic gynecological surgery: A randomized controlled trial.

Authors:  Peng Zhao; Yunfeng Cui; Lihua Sun; Xufang Sun
Journal:  Exp Ther Med       Date:  2020-11-19       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.